PT3094616T - O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativos - Google Patents
O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativosInfo
- Publication number
- PT3094616T PT3094616T PT157373291T PT15737329T PT3094616T PT 3094616 T PT3094616 T PT 3094616T PT 157373291 T PT157373291 T PT 157373291T PT 15737329 T PT15737329 T PT 15737329T PT 3094616 T PT3094616 T PT 3094616T
- Authority
- PT
- Portugal
- Prior art keywords
- composition containing
- neurodegenerative disorders
- containing glyceryl
- glyceryl tribenzoate
- tribenzoate
- Prior art date
Links
- HIZCTWCPHWUPFU-UHFFFAOYSA-N Glycerol tribenzoate Chemical compound C=1C=CC=CC=1C(=O)OCC(OC(=O)C=1C=CC=CC=1)COC(=O)C1=CC=CC=C1 HIZCTWCPHWUPFU-UHFFFAOYSA-N 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461928622P | 2014-01-17 | 2014-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3094616T true PT3094616T (pt) | 2021-03-03 |
Family
ID=53543490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT157373291T PT3094616T (pt) | 2014-01-17 | 2015-01-16 | O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9968582B2 (enExample) |
| EP (1) | EP3094616B1 (enExample) |
| JP (2) | JP6836905B2 (enExample) |
| CA (1) | CA2936548C (enExample) |
| CY (1) | CY1124115T1 (enExample) |
| DK (1) | DK3094616T3 (enExample) |
| ES (1) | ES2853974T3 (enExample) |
| HR (1) | HRP20210361T1 (enExample) |
| HU (1) | HUE053671T2 (enExample) |
| LT (1) | LT3094616T (enExample) |
| PL (1) | PL3094616T3 (enExample) |
| PT (1) | PT3094616T (enExample) |
| RS (1) | RS61611B1 (enExample) |
| SI (1) | SI3094616T1 (enExample) |
| SM (1) | SMT202100074T1 (enExample) |
| WO (1) | WO2015109215A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11304923B2 (en) | 2017-10-06 | 2022-04-19 | Rush University Medical Center | Use of a benzoate containing composition to treat glycine encephalopathy |
| US11826326B2 (en) * | 2017-11-22 | 2023-11-28 | Excelsior Pharmatech Labs | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
| AU2020229316A1 (en) * | 2019-02-25 | 2021-09-16 | Rush University Medical Center | Compositions including cinnamic acid and methods of use thereof |
| JP2022541021A (ja) * | 2019-07-16 | 2022-09-21 | ラッシュ・ユニバーシティ・メディカル・センター | 神経変性障害を治療するためのベンゾエート含有組成物の使用 |
| WO2022093922A1 (en) * | 2020-10-28 | 2022-05-05 | Rush University Medical Center | Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders |
| EP4262781A4 (en) * | 2020-12-16 | 2025-02-12 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
| CA3241282A1 (en) * | 2021-12-16 | 2023-06-22 | Kalipada PAHAN | Benzoic acid salts for treatment of nervous system injuries and disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) * | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| WO2008083226A2 (en) | 2006-12-28 | 2008-07-10 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
-
2015
- 2015-01-16 HU HUE15737329A patent/HUE053671T2/hu unknown
- 2015-01-16 SI SI201531511T patent/SI3094616T1/sl unknown
- 2015-01-16 SM SM20210074T patent/SMT202100074T1/it unknown
- 2015-01-16 JP JP2016565117A patent/JP6836905B2/ja active Active
- 2015-01-16 ES ES15737329T patent/ES2853974T3/es active Active
- 2015-01-16 CA CA2936548A patent/CA2936548C/en active Active
- 2015-01-16 DK DK15737329.1T patent/DK3094616T3/da active
- 2015-01-16 PL PL15737329T patent/PL3094616T3/pl unknown
- 2015-01-16 US US15/110,702 patent/US9968582B2/en active Active
- 2015-01-16 EP EP15737329.1A patent/EP3094616B1/en active Active
- 2015-01-16 WO PCT/US2015/011798 patent/WO2015109215A1/en not_active Ceased
- 2015-01-16 HR HRP20210361TT patent/HRP20210361T1/hr unknown
- 2015-01-16 RS RS20210230A patent/RS61611B1/sr unknown
- 2015-01-16 PT PT157373291T patent/PT3094616T/pt unknown
- 2015-01-16 LT LTEP15737329.1T patent/LT3094616T/lt unknown
-
2019
- 2019-10-18 JP JP2019191224A patent/JP2020037558A/ja active Pending
-
2021
- 2021-03-09 CY CY20211100204T patent/CY1124115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1124115T1 (el) | 2022-05-27 |
| WO2015109215A1 (en) | 2015-07-23 |
| CA2936548C (en) | 2022-08-30 |
| EP3094616B1 (en) | 2020-12-23 |
| RS61611B1 (sr) | 2021-04-29 |
| JP6836905B2 (ja) | 2021-03-03 |
| US9968582B2 (en) | 2018-05-15 |
| EP3094616A4 (en) | 2017-08-23 |
| JP2020037558A (ja) | 2020-03-12 |
| PL3094616T3 (pl) | 2021-05-31 |
| US20160331714A1 (en) | 2016-11-17 |
| JP2017505811A (ja) | 2017-02-23 |
| SMT202100074T1 (it) | 2021-05-07 |
| HRP20210361T1 (hr) | 2021-04-16 |
| DK3094616T3 (da) | 2021-02-15 |
| LT3094616T (lt) | 2021-04-12 |
| HUE053671T2 (hu) | 2021-07-28 |
| ES2853974T3 (es) | 2021-09-20 |
| CA2936548A1 (en) | 2015-07-23 |
| EP3094616A1 (en) | 2016-11-23 |
| SI3094616T1 (sl) | 2021-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| PT3079666T (pt) | Composições farmacêuticas que contêm fumarato de dimetilo | |
| DK3223827T3 (da) | Kostfibersammensætning | |
| PT3094616T (pt) | O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativos | |
| EP3395325A4 (en) | LIQUID COSMETIC COMPOSITION | |
| IL250649A0 (en) | Topical composition containing ranpirnase | |
| PL3207149T3 (pl) | Kompozycja farmaceutyczna o zwiększonej stabilności | |
| BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
| BR112016030507A2 (pt) | Compostos relacionados à vitamina d, composição farmacêutica, e kit | |
| EP3134147C0 (en) | WASHING PRODUCT FOR INTIMATE USE | |
| PL3474858T3 (pl) | Dwuskładnikowa kompozycja zawierająca kwas acetylosalicylowy | |
| DK3369429T3 (da) | Farmaceutisk sammensætning tiltænkt at blive administreret til næseslimhinden | |
| FR3021528B1 (fr) | Formulation cosmetique | |
| DK3089740T3 (da) | Farmaceutisk sammensætning | |
| EP3441073A4 (en) | MEDICAL COMPOSITION | |
| PL3313369T3 (pl) | Kompozycja emolientu | |
| PL3250181T3 (pl) | Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw | |
| FR3039766B1 (fr) | Composition cosmetique exfoliante | |
| BR112016018011A2 (pt) | kit para a preparação de um produto radiofarmacêutico | |
| BR112017012107A2 (pt) | composição de dentifrício para clareamento estável com estética superior | |
| FR3026639B1 (fr) | Composition cosmetique | |
| PT2956129T (pt) | Composições farmacêuticas que contêm dexcetoprofeno e tramadol | |
| FR3032614B1 (fr) | Composition cosmetique nettoyante | |
| BR112015030989A2 (pt) | composição farmacêutica, e, uso de uma composição | |
| EP3563845A4 (en) | PHARMACEUTICAL COMPOSITION |